BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36914878)

  • 1. Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS).
    Yan M; Lee M; Myrehaug S; Tseng CL; Detsky J; Chen H; Das S; Yeboah C; Lipsman N; Costa LD; Holden L; Heyn C; Maralani P; Ruschin M; Sahgal A; Soliman H
    J Neurooncol; 2023 Mar; 162(1):119-128. PubMed ID: 36914878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma knife icon based hypofractionated stereotactic radiosurgery (GKI-HSRS) for brain metastases: impact of dose and volume.
    Yan M; Holden L; Wang M; Soliman H; Myrehaug S; Tseng CL; Detsky J; Ruschin M; Tjong M; Atenafu EG; Das S; Lipsman N; Heyn C; Sahgal A; Husain Z
    J Neurooncol; 2022 Sep; 159(3):705-712. PubMed ID: 35999435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases.
    Sneed PK; Chan JW; Ma L; Braunstein SE; Theodosopoulos PV; Fogh SE; Nakamura JL; Boreta L; Raleigh DR; Ziemer BP; Morin O; Hervey-Jumper SL; McDermott MW
    J Neurosurg; 2023 Jan; 138(1):104-112. PubMed ID: 35594891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
    Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
    J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastases.
    Andruska N; Kennedy WR; Bonestroo L; Anderson R; Huang Y; Robinson CG; Abraham C; Tsien C; Knutson N; Rich KM; Spencer C; Huang J
    Radiother Oncol; 2021 Mar; 156():181-187. PubMed ID: 33310010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain Metastases.
    Faruqi S; Ruschin M; Soliman H; Myrehaug S; Zeng KL; Husain Z; Atenafu E; Tseng CL; Das S; Perry J; Maralani P; Heyn C; Mainprize T; Sahgal A
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):772-779. PubMed ID: 31928848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reirradiation With Stereotactic Radiosurgery After Local or Marginal Recurrence of Brain Metastases From Previous Radiosurgery.
    Kowalchuk RO; Niranjan A; Lee CC; Yang HC; Liscak R; Guseynova K; Tripathi M; Kumar N; Peker S; Samanci Y; Hess J; Chiang V; Iorio-Morin C; Mathieu D; Pikis S; Wei Z; Lunsford LD; Trifiletti DM; Sheehan JP
    Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):726-734. PubMed ID: 34644606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
    Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Second Course of Stereotactic Image-Guided Robotic Radiosurgery for Patients with Cerebral Metastasis.
    Jiang X; Wang H; Song Y; Wang X; Li F; Dong Y; Wang J; Chen H; Yuan Z
    World Neurosurg; 2019 Mar; 123():e621-e628. PubMed ID: 30553069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyberknife
    Telentschak S; Ruess D; Grau S; Goldbrunner R; von Spreckelsen N; Jablonska K; Treuer H; Kocher M; Ruge M
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2765-2773. PubMed ID: 33638006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator-based hypofractionated stereotactic radiosurgery for intact intracranial metastases.
    Zhang Q; Hamilton D; Conway P; Xie SJ; Haghighi N; Lasocki A
    J Med Imaging Radiat Oncol; 2023 Apr; 67(3):308-319. PubMed ID: 36847751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-Volume Tolerance of the Brain and Predictors of Radiation Necrosis After 3-Fraction Radiosurgery for Brain Metastases: A Large Single-Institutional Analysis.
    Upadhyay R; Ayan AS; Jain S; Klamer BG; Perlow HK; Zoller W; Blakaj DM; Beyer S; Grecula J; Arnett A; Thomas E; Chakravarti A; Raval RR; Palmer JD
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):275-284. PubMed ID: 37574170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection.
    Kurtz G; Zadeh G; Gingras-Hill G; Millar BA; Laperriere NJ; Bernstein M; Jiang H; Ménard C; Chung C
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):137-42. PubMed ID: 24331660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Let's make size not matter: tumor control and toxicity outcomes of hypofractionated Gamma Knife radiosurgery for large brain metastases.
    Mishra A; Koffler D; Calugaru E; Rowe N; Viswanatha SD; Begley S; Bajaj V; Schulder M; Goenka A
    J Neurooncol; 2023 Jul; 163(3):587-595. PubMed ID: 37410346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.